We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current GBIO market cap is 179.49M. The company's latest EPS is USD -1.9046 and P/E is -1.42.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 880k | 2.15M | 2.88M | 4.06M |
| Operating Income | -34.87M | -33.92M | -28.71M | -38.42M | -77.63M |
| Net Income | -32.09M | -31.07M | -28.27M | -35.19M | -74.54M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 5.9M |
| Operating Income | -62.3M | -81.11M | -119.1M | -141.18M | -138.56M |
| Net Income | -61.32M | -80.52M | -119.05M | -136.64M | -126.61M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 431.42M | 404.88M | 381.49M | 374.76M | 285.88M |
| Total Liabilities | 152.28M | 150.6M | 149.58M | 171.63M | 153.89M |
| Total Equity | 279.14M | 254.29M | 231.91M | 203.13M | 131.99M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 42.14M | 294.16M | 476.77M | 376.26M | 374.76M |
| Total Liabilities | 25.14M | 26.14M | 95.03M | 93.77M | 171.63M |
| Total Equity | -98.59M | 268.01M | 381.75M | 282.49M | 203.13M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -27.68M | -2.87M | -27.77M | -52.75M | -31.7M |
| Investing | -5.62M | 18.8M | -7.78M | -9.7M | -553k |
| Financing | 35.77M | 35.87M | 35.74M | 35.82M | -125k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -40.35M | -70.14M | -91.82M | -102.45M | -52.75M |
| Investing | 47.99M | -205.2M | 193.05M | -192.52M | -9.7M |
| Financing | 78k | 323.1M | 214.67M | 12.99M | 35.82M |
| Market Cap | 179.49M |
| Price to Earnings Ratio | -1.42 |
| Price to Sales Ratio | 30.41 |
| Price to Cash Ratio | 2.7 |
| Price to Book Ratio | 0.88 |
| Dividend Yield | - |
| Shares Outstanding | 66.48M |
| Average Volume (1 week) | 128.45k |
| Average Volume (1 Month) | 118.66k |
| 52 Week Change | -46.95% |
| 52 Week High | 6.98 |
| 52 Week Low | 0.86 |
| Spread (Intraday) | 0.79 (25.32%) |
| Company Name | Generation Bio Company |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.generationbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
